There have been 44 initial public offerings (IPOs) listed on the US stock markets in 2024 thus far, many of which continue to trade at a premium to their initial offering price, demonstrating the strength and buoyancy of...more
4/16/2024
/ Acquisitions ,
Capital Markets ,
Disclosure Requirements ,
Dual Track Process ,
Initial Public Offering (IPO) ,
Interest Rates ,
Life Sciences ,
Mergers ,
Price Inflation ,
Private Equity ,
Securities and Exchange Commission (SEC) ,
Shareholders ,
Stock Prices ,
Valuation ,
Wages
On January 30, 2024, McDermott Partners Edward (Jed) Gordon, Kate Vera, and Todd Kornfeld and Associate Allison McSorley Tassel discussed on a panel the current market conditions and shared different capital raising options...more
2/12/2024
/ Acquisitions ,
Artificial Intelligence ,
Capital Raising ,
Corporate Governance ,
Cybersecurity ,
Domestic Dealmaking ,
Emerging Growth Companies ,
Executive Compensation ,
Incident Response Plans ,
Information Technology ,
Intellectual Property Protection ,
Machine Learning ,
Mergers ,
Recordkeeping Requirements ,
Startups
Please join McDermott for our highly anticipated Life Sciences Dealmaking Symposium! Now in its 12th year, the Symposium offers a unique platform for education, insight sharing, purposeful networking and strategic...more
10/23/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Valuations ,
Capital Markets ,
Capital Raising ,
Carve Out Provisions ,
Collaboration ,
Cross-Border Transactions ,
Events ,
Health Care Providers ,
Health Technology ,
Initial Public Offering (IPO) ,
Investors ,
IP License ,
IP Portfolio ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity Firms ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)